A longitudinal 5-year study for the prediction of HCC, death and liver decompensation by ARFI elastography

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031824

Enrollment

573

Registered

2023-05-08

Start date

2018-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K74.0

Interventions

Group 1: Patients with an elastography examination of the liver between 2010 and 2012 and a follow up of 5 years at the Erlangen University Hospital were included in the study

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Correct ARFI measurement (at least 5 measurements) of the right liver lobe, follow-up patient data of at least 5 years after ARFI measurement

Exclusion criteria

Exclusion criteria: Inadequate ARFI measurement, no complete follow-up data during the observation period

Design outcomes

Primary

Measure	Time frame
Liver related survival	—

Secondary

Measure	Time frame
Overall survival, occurrence of HCC, occurrence of liver decompensation/variceal bleeding	—

Countries

Germany

Contacts

Public ContactLukas Pfeifer

Klinik für Gastroenterologie und interventionelle Endoskopie, Krankenhaus Barmherzige Brüder Regensburg

lukas.pfeifer@barmherzige-regensburg.de+4994136992062

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026